Data Visualization and Interpretation Examples

ImmuneComposition page

PatientHeterogenity page

FunctionalAnalysis page

Mixing Score and Stratification 2

Correlations, Pattern analysis page

Custom Panels Available Upon Request:

Publication list:

  • Gunderson et al., Cancer Disc (2016). PMID: 26715645n response to standard of care treatment, in response to immune treatment and longitudinal biopsies
  • Tsujikawa et al., Cell Rep (2017). PMID: 28380359
  • Chang et al., CPIEEE (2017). PMID: 29060785
  • Liu et al, J Invest Derm (2017). PMID: 27720760
  • Gopalakrishnan et al., Science (2018). PMID: 29097493
  • Saung et al., J Immunother Cancer (2018). PMID 30424804
  • Pennock et al., JITC (2018). PMID:30285905
  • Lane et al., J Exp Med (2018). PMID: 30381467
  • Li et al., Immunity (2018). PMID: 29958801
  • Tsujikawa et al., Cytometry (2019). PMID: 30714674
  • Means et al., Head Neck (2019). PMID: 30896061
  • Cassetta et al., Cancer Cell (2019). PMID: 30930117
  • Reddy et al., Can Immuno Res (2019). PMID: 31043414
  • Blair et al., Clin Cancer Res (2019). PMID: 31186314
  • Hassan et al., Clin Cancer Res (2019). PMID: 31263030
  • Hundeyin et al., Cancer Discov (2019). PMID: 31266770
  • Michaelis et al., Nat. Comm. (2019). PMID: 31729370
  • Banik et al., Methods in Enz. (2020). PMID: 32122539
  • Pennycuick et al., Cancer Discovery (2020). PMID: 32690541

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More